Editor's Note: Frank Douglas resigned from senior positions at MIT earlier this summer, in the wake of the Institute's controversial denial of tenure to James Sherley, who staged a hunger strike in protest in February. In this piece, which will run in the October issue of The Scientist, Douglas describes his reasons for resigning, which go beyond the Sherley case. We're publishing it early online to spark a discussion of diversity on university campuses. Please comment on this piece and related issues by clicking here.On June 3, I resigned from faculty and administrative positions at MIT, effective June 30. I did so because I perceived an unconscious discrimination against minorities and because my colleagues and the institute authorities did not act on my recommendations to address these issues. The timing was such that many of my colleagues thought I was resigning over the case of James...
MIT: from women to BiDilThe James Sherley caseWhat next?Frank Douglas is the former Professor of the Practice at MIT and director of MIT's Center for Biomedical Innovation. He also serves on the board of directors of several pharmaceutical companies, including NitroMed, which developed the drug BiDil.hereThe Scientisthttp://www.the-scientist.com/blog/display/52855The Scientisthttp://www.the-scientist.com/supplement/2006-11-01

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!